Radiation nephropathy.
Cohen EP, Robbins ME.
Semin Nephrol. 2003 Sep;23(5):486-99. doi: 10.1016/s0270-9295(03)00093-7.
The Potential Effects of Taurine in Mitigation of Radiation Nephropathy.
Ma N, Kato T, Isogai T, Gu Y, Yamashita T.
Adv Exp Med Biol. 2019;1155:497-505. doi: 10.1007/978-981-13-8023-5_46.
Radiation nephropathy: a review.
Robbins ME, Bonsib SM.
Scanning Microsc. 1995 Jun;9(2):535-60.
Radiation nephropathy: Mechanisms of injury and recovery in a murine model.
Ahmad A, Shi J, Ansari S, Merscher S, Pollack A, Zeidan Y, Fornoni A, Marples B.
Radiother Oncol. 2023 Oct;187:109813. doi: 10.1016/j.radonc.2023.109813. Epub 2023 Jul 17.
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists.
Moulder JE, Fish BL, Cohen EP.
Curr Pharm Des. 2007;13(13):1317-25. doi: 10.2174/138161207780618821.
Bone Pain in Cancer Patients: Mechanisms and Current Treatment.
Zajączkowska R, Kocot-Kępska M, Leppert W, Wordliczek J.
Int J Mol Sci. 2019 Nov 30;20(23):6047. doi: 10.3390/ijms20236047.
Peptide receptor radionuclide therapy: a new era of radiation nephropathy.
Das A, Kendi AT, Manohar S.
Nephrol Dial Transplant. 2026 Jan 30;41(2):220-232. doi: 10.1093/ndt/gfaf121.
TOXIC NEPHROPATHY.
SCHREINER GE, MAHER JF.
Am J Med. 1965 Mar;38:409-49. doi: 10.1016/0002-9343(65)90149-x.
Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors.
Zheng W, Li H, Go Y, Chan XHF, Huang Q, Wu J.
Nutrients. 2022 Nov 1;14(21):4588. doi: 10.3390/nu14214588.
Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy.
Cohen EP, Fish BL, Moulder JE.
Curr Drug Targets. 2010 Nov;11(11):1423-9. doi: 10.2174/1389450111009011423.
